Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Published:2023-02 Issue:2 Volume:8 Page:157-168
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Ghaneh Paula,Palmer Daniel,Cicconi Silvia,Jackson Richard,Halloran Christopher Michael,Rawcliffe Charlotte,Sripadam Rajaram,Mukherjee Somnath,Soonawalla Zahir,Wadsley Jonathan,Al-Mukhtar Ahmed,Dickson Euan,Graham Janet,Jiao Long,Wasan Harpreet S,Tait Iain S,Prachalias Andreas,Ross Paul,Valle Juan W,O'Reilly Derek A,Al-Sarireh Bilal,Gwynne Sarah,Ahmed Irfan,Connolly Kate,Yim Kein-Long,Cunningham David,Armstrong Thomas,Archer Caroline,Roberts Keith,Ma Yuk Ting,Springfeld Christoph,Tjaden Christine,Hackert Thilo,Büchler Markus W,Neoptolemos John P

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Pancreatic cancer;Kleeff;Nat Rev Dis Primers,2016

2. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

3. Optimizing the outcomes of pancreatic cancer surgery;Strobel;Nat Rev Clin Oncol,2019

4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial;Neoptolemos;Lancet,2001

5. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response;Translational Oncology;2024-11

2. The Role of Surgery in “Oligometastatic” Pancreas Cancer;Surgical Clinics of North America;2024-10

3. Locally Advanced Pancreas Cancer, Is There a Role for Surgery?;Surgical Clinics of North America;2024-10

4. Indications for Radiation in Pancreatic Adenocarcinoma;Surgical Clinics of North America;2024-10

5. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02